Violations of Exhibiting and FDA Rules at an American Psychiatric Association Annual Meeting
- 7 December 2005
- journal article
- Published by Springer Science and Business Media LLC in Journal of Public Health Policy
- Vol. 26 (4), 389-399
- https://doi.org/10.1057/palgrave.jphp.3200049
Abstract
We conducted a cross-sectional study of all exhibit booths for the 24 pharmaceutical companies at the 2002 American Psychiatric Association (APA) convention. We collected and categorized one of each item distributed by the companies at each booth. A total of 268 items were collected from 24 companies (median=8). The most common categories of items were "reprints or pamphlets" (37%) and "noneducational gifts" (27%), including music CDs and invitations to dinners and museums. There were a total of 16 violations of the APA's own exhibit rules: eight companies had one violation and two companies had four violations. Four companies engaged in FDA-prohibited off-label promotion; one also violated the APA code. Over half of all companies (54%) were in violation of either APA rules or FDA regulations. The APA's voluntary code has failed to adequately reduce inappropriate promotional activity at the annual APA meeting.Keywords
This publication has 6 references indexed in Scilit:
- Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotionsAmerican Journal Of Medicine, 2001
- Medical Professionalism — Focusing on the Real IssuesNew England Journal of Medicine, 2000
- Physicians and the Pharmaceutical IndustryJama-Journal Of The American Medical Association, 2000
- Complimentary journeys to the World Congress of Gastroenterology - an inquiry of potential sponsors and beneficiariesZeitschrift für Gastroenterologie, 2000
- Characteristics of materials distributed by drug companiesJournal of General Internal Medicine, 1996
- The Effects of Pharmaceutical Firm Enticements on Physician Prescribing PatternsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1992